Coffee and tea consumption and the risk of ovarian cancer: A prospective cohort study and updated meta-analysis

American Journal of Clinical Nutrition

Volumn 95, Issue 5, 2012, Pages 1172-1181

  Braem, Marieke G M ^a   Onland Moret, N Charlotte ^a   Schouten, Leo J ^b   Tjønneland, Anne ^c,l,m   Hansen, Louise ^c   Dahm, Christina C ^d,e   Overvad, Kim ^e   Lukanova, Annekatrin ^f   Dossus, Laure ^f   Floegel, Anna ^g   Boeing, Heiner ^g   Clavel Chapelon, Francoise ^h,i   Chabbert Buffet, Nathalie ^j,k   Fagherazzi, Guy ^h,i   Trichopoulou, Antonia ^c,l,m   Benetou, Vassiliki ^l   Goufa, Ioulia ^m   Pala, Valeria ⁿ   Galasso, Rocco ^o   Mattiello, Amalia ^p   Sacerdote, Carlotta ^q   Palli, Domenico ^r   Tumino, Rosario ^s   Gram, Inger T ^t   Lund, Eiliv ^t   Gavrilyuk, Oxana ^t   Sánchez, Maria José ^u,v   Quirós, Ramón ^w   Gonzales, Carlos A ^x   Dorronsoro, Miren ^y   Huerta Castaño, José M ^v,z   Gurrea, Aurelio Barricarte ^v,aa   Idahl, Annika ^ab   Ohlson, Nina ^ab   Lundin, Eva ^ab   Jirstrom, Karin ^ac   Wirfalt, Elisabet ^ad   Allen, Naomi E ^ae   Tsilidis, Konstantinos K ^ae   Kaw, Kay Tee ^af   Bueno de Mesquita, H Bas ^a,ag   Dik, Vincent K ^a   Rinaldi, Sabina ^ah   Fedirko, Veronika ^ah   Norat, Teresa ^ai   Riboli, Elio ^ai   Kaaks, Rudolf ^f   Peeters, Petra H M ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h INSERM   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j HÔPITAL TENON   (France)

^k SORBONNE UNIVERSITÉ   (France)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m HELLENIC HEALTH FOUNDATION   (Greece)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^p UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^q HuGeF Foundation and CPO Piemonte   (Italy)

^r CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^s CIVILE M P AREZZO HOSPITAL   (Italy)

^t UNIVERSITY OF TROMSØ   (Norway)

^u ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^v Consortium for Biomedical Research in Epidemiology and Public Health ^*  (Spain)

^w Public Health and Health Planning Directorate   (Spain)

^x BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^y Basque Government   (Spain)

^z Murcia Regional Health Authority   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac LUND UNIVERSITY   (Sweden)

^ad LUND UNIVERSITY HOSPITAL   (Sweden)

^ae UNIVERSITY OF OXFORD   (United Kingdom)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ah INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ai IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; COFFEE; DENMARK; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FRANCE; GERMANY; GREECE; HEREDITY; HORMONAL THERAPY; HUMAN; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; NETHERLANDS; NORWAY; ORAL CONTRACEPTION; OVARY CANCER; PHYSICAL ACTIVITY; PREGNANCY; PROSPECTIVE STUDY; SMOKING; SPAIN; SWEDEN; TEA; UNITED KINGDOM;

COFFEE; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS AS TOPIC; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TEA;

EID: 84860298595     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.026393     Document Type: Article

References (42)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AIRC, 2007.
2. Steevens J, Schouten LJ, Verhage BAJ, Goldbohm RA, van den Brandt PA. Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 2007;97: 1291-4. (Pubitemid 350035805)
3. Zhou B, Yang L, Wang L, Shi Y, Zhu H, Tang N, Wang B. The association of tea consumption with ovarian cancer risk: a meta-analysis. Am J Obstet Gynecol 2007;197:594.e1-6.
4. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
5. Riboli E, Kaaks R. The EPIC project: rationale and study design. Int J Epidemiol 1997;26:S6-14.
6. Margetts BM, Pietinen P. European Prospective Investigation into Cancer and Nutrition: validity studies on dietary assessment methods. Int J Epidemiol 1997;26(suppl 1):S1-5. (Pubitemid 27129684)
7. Kotsopoulos J, Vitonis AF, Terry KL, De Vivo I, Cramer DW, Hankinson SE, Tworoger SS. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control 2009;20:335-44.
8. Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000;88:313-8.
9. Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 2008;112:1169-77. (Pubitemid 351304604)
10. Lueth NA, Anderson KE, Harnack LJ, Fulkerson JA, Robien K. Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study. Cancer Causes Control 2008;19:1365-72.
11. Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 2010;21:1533-44.
12. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
13. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
14. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata Journal 2006;6:40.
15. Larsson SC, Wolk A. Coffee consumption is not associated with ovarian cancer incidence. Cancer Epidemiol Biomarkers Prev 2005;14: 2273-4. (Pubitemid 41603280)
16. Silvera SAN, Jain M, Howe GR, Miller AB, Rohan TE. Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer 2007;58:22-7. (Pubitemid 47076158)
17. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994;5: 401-8. (Pubitemid 24302703)
18. Larsson SC, Wolk A. Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 2005;165:2683-6. (Pubitemid 41785069)
19. Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996;144:175-82. (Pubitemid 26234996)
20. Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 2007;121:2225-32. (Pubitemid 47585602)
21. Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 2011;11:96.
22. Miller DR, Rosenberg L, Kaufman DW, Helmrich SP, Schottenfeld D, Lewis J, Stolley PD, Rosenshein N, Shapiro S. Epithelial ovarian-cancer and coffee-drinking. Int J Epidemiol 1987;16:13-7.
23. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:712-6. (Pubitemid 351469224)
24. Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KF, Villella JA, Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer 2007;17:50-4. (Pubitemid 46213969)
25. Tavani A, Gallus S, Dal Maso L, Franceschi S, Montella M, Conti E, La Vecchia C. Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study. Nutr Cancer 2001;39:29-34. (Pubitemid 32880945)
26. Ferruzzi MG. The influence of beverage composition on delivery of phenolic compounds from coffee and tea. Physiol Behav 2010;100:33-41.
27. Tai J, Cheung S, Chan E, Hasman D. Antiproliferation effect of commercially brewed coffees on human ovarian cancer cells in vitro. Nutr Cancer 2010;62:1044-57.
28. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Vol 60. Lyon, France: International Agency for Research on Cancer, 1994.
29. Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2304-13. (Pubitemid 351196362)
30. Wilson KM, Mucci LA, Rosner BA, Willett WC. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev 2010;19:2503-15.
31. Hogervorst JGF, Baars BJ, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA. The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 2010;40:485-512.
32. Ali SF, Hong J-S, Wilson WE, Uphouse LL, Bondy SC. Effect of acrylamide on neurotransmitter metabolism and neuropeptide levels in several brain regions and upon circulating hormones. Arch Toxicol 1983;52:35-43. (Pubitemid 13170260)
33. Khan MA, Davis CA, Foley GL, Friedman MA, Hansen LG. Changes in thyroid gland morphology after acute acrylamide exposure. Toxicol Sci 1999;47:151-7. (Pubitemid 29214821)
34. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 2009;115:2765-74.
35. Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 1996;144:642-4. (Pubitemid 26322515)
36. Lucero J, Harlow BL, Barbieri RL, Sluss P, Cramer DW. Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use. Fertil Steril 2001;76:723-9. (Pubitemid 32928398)
37. Yang CS, Prabhu S, Landau J. Prevention of carcinogenesis by tea polyphenols. Drug Metab Rev 2001;33:237-53. (Pubitemid 33136264)
38. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007;81:519-33. (Pubitemid 47212236)
39. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002;113:71S-88S. (Pubitemid 36151834)
40. Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 2010;501:65-72.
41. Bushman JL. Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998;31:151-9. (Pubitemid 28481848)
42. Sun C-L, Yuan J-M, Koh W-P, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006;27:1310-5. (Pubitemid 43985405)